510(k) K234015
K234015 is an FDA 510(k) premarket notification submitted by Eusa Pharma (Uk) Limited for the device "Caphosol® Artifical Saliva (32 doses sachet box)". The FDA issued a decision of Substantially Equivalent on Mar 11, 2024. The device falls under product code LFD (Saliva, Artificial), a Class U device. Eusa Pharma (Uk) Limited has 1 other 510(k) clearance on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Mar 11, 2024
- Date Received
- Dec 19, 2023
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Saliva, Artificial
- Device Class
- Class U
- Review Panel
- DE
- Submission Type
- 510(k)
Need the full FDA record for Eusa Pharma (Uk) Limited? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.